Inhibrx Biosciences, Inc. INBX Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s preferred stock, par or stated value per share?
- Inhibrx Biosciences, Inc. (INBX) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Inhibrx Biosciences, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s preferred stock, par or stated value per share?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.